Weibin Liu is an Analyst at KPCB China.  Prior to joining KPCB in 2008, he worked at DFJ DragonFund, where he supported venture investments in life science, healthcare, and greentech.  He has also worked in systems engineering at Novartis, investment management at Morgan Stanley, and molecular neuroscience research at the Zanvyl Krieger Mind/Brain Institute. 

Weibin earned a BS with honors in Molecular Biology and an MS in Biotechnology from Johns Hopkins University.  

E-mail: weibinl@kpcb.com